Personal Pharmacist Update

Notices, tips, clinical information and system updates targeted toward Personal Pharmacists.


	Recall of Lo/Ovral-28(Norgestrel/EthinylEstradiol) Tablets 01/16/2012 On February 1, 2012, Pfizer Inc. issued a recall on the oral contraceptive Lo/Ovral-28 (Norgestrel/Ethinyl Estradiol).
	FDA Approves Edarbyclor™ 01/09/2012 The FDA recently announced its approval of Edarbyclor ™, a combination hypertension product containing the angiotensin receptor blocker azilsartan and the diuretic, chlorthalidone.
	Voluntary Recall of Over-the-Counter Products Issued by Novartis Consumer Health Inc. 01/02/2012 On January 8, 2012, Novartis issued a nationwide recall on certain over-the-counter (OTC) medications, including Excedrin, NoDoz, Bufferin, and Gas-X Prevention products.
	FDA Approves New Potential game Changing Long-Acting Bronchodilator for COPD 12/26/2011 Arcapta (Indacaterol), the first ultra-long-acting beta agonist (LABA), was approved by the FDA July 1, 2011 and is slated for initial marketing first quarter 2012.
	Glycemic Control and Hypoglycemia in Patients Converted from Glyburide to Glipizide 12/19/2011 A recently published study in the Journal of Managed Care Pharmacy provides results consistent with the American Diabetes Association’s recommendation to administer glipizide over glyburide in diabetic patients.
1 2 3